Novel coronavirus-like particles targeting cells lining the respiratory tract.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30183777.
- Also identified by DOI 10.1371/journal.pone.0203489 and PMC identifier 6124810.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Virus like particles (VLPs) produced by the expression of viral structural proteins can serve as versatile nanovectors or potential vaccine candidates. In this study we describe for the first time the generation of HCoV-NL63 VLPs using baculovirus system. Major structural proteins of HCoV-NL63 have been expressed in tagged or native form, and their assembly to form VLPs was evaluated. Additionally, a novel procedure for chromatography purification of HCoV-NL63 VLPs was developed. Interestingly, we show that these nanoparticles may deliver cargo and selectively transduce cells expressing the ACE2 protein such as ciliated cells of the respiratory tract. Production of a specific delivery vector is a major challenge for research concerning targeting molecules. The obtained results show that HCoV-NL63 VLPs may be efficiently produced, purified, modified and serve as a delivery platform. This study constitutes an important basis for further development of a promising viral vector displaying narrow tissue tropism.
Medical subject headings
- Coronavirus NL63, Human
- Drug Delivery Systems
- Nanoparticles
- Peptidyl-Dipeptidase A
- Respiratory Mucosa
- Vaccines, Virus-Like Particle